{"id":"https://openalex.org/W7220830574","doi":"https://doi.org/10.3389/fphar.2026.1942461","title":"Safety, pharmacokinetics and pharmacodynamics of ICP-332, an oral TYK2 inhibitor, in healthy participants: a randomized, double-blind, placebo-controlled phase I study","display_name":"Safety, pharmacokinetics and pharmacodynamics of ICP-332, an oral TYK2 inhibitor, in healthy participants: a randomized, double-blind, placebo-controlled phase I study","publication_year":2026,"publication_date":"2026-10-07","ids":{"openalex":"https://openalex.org/W7220830574","doi":"https://doi.org/10.3389/fphar.2026.1942461","pmid":"https://pubmed.ncbi.nlm.nih.gov/42948471","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13711260"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1942461","doi":"https://doi.org/10.3389/fphar.2026.1942461","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1942461","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1942461/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1942461/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5157837431","display_name":"Hengli Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hengli Zhao","raw_affiliation_strings":["Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China","institution_ids":["https://openalex.org/I4210163399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006035416","display_name":"Yilin Wei","orcid":"https://orcid.org/0000-0002-5685-9856","observed_orcids":["https://orcid.org/0000-0002-5685-9856"]},"institutions":[{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yilin Wei","raw_affiliation_strings":["Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China","institution_ids":["https://openalex.org/I4210163399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023871304","display_name":"Yu Jiang","orcid":"https://orcid.org/0000-0001-7344-7274","observed_orcids":["https://orcid.org/0000-0001-7344-7274","https://orcid.org/0000-0001-7238-1701","https://orcid.org/0009-0009-3172-4777"]},"institutions":[{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yu jiang","raw_affiliation_strings":["Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China","institution_ids":["https://openalex.org/I4210163399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102833083","display_name":"Kun He","orcid":"https://orcid.org/0000-0002-1027-1854","observed_orcids":["https://orcid.org/0000-0002-1027-1854"]},"institutions":[{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Kun He","raw_affiliation_strings":["Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China","institution_ids":["https://openalex.org/I4210163399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100784906","display_name":"Xiaoran Zhang","orcid":"https://orcid.org/0000-0002-4654-6055","observed_orcids":["https://orcid.org/0000-0002-4654-6055"]},"institutions":[{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaoran Zhang","raw_affiliation_strings":["Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China","institution_ids":["https://openalex.org/I4210163399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157835967","display_name":"Rui Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Rui Li","raw_affiliation_strings":["Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China","institution_ids":["https://openalex.org/I4210163399"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055799241","display_name":"Qing Wen","orcid":"https://orcid.org/0000-0002-6408-2370","observed_orcids":["https://orcid.org/0000-0002-6408-2370"]},"institutions":[{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Qing Wen","raw_affiliation_strings":["Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China","institution_ids":["https://openalex.org/I4210163399"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5055799241"],"corresponding_institution_ids":["https://openalex.org/I4210163399"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.67581881,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1942461","last_page":"1942461"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.3337000012397766,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.3337000012397766,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.23119999468326569,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.15629999339580536,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tyk2-inhibitor","display_name":"TYK2 inhibitor","score":0.9819999933242798},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.6420000195503235},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.996999979019165},{"id":"https://openalex.org/keywords/food-effect","display_name":"food effect","score":0.8600000143051147},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.7889999747276306},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.7519999742507935},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":0.9010000228881836},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6259999871253967},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.8320000171661377},{"id":"https://openalex.org/keywords/single-ascending-dose","display_name":"single ascending dose","score":0.7160000205039978},{"id":"https://openalex.org/keywords/multiple-ascending-dose","display_name":"multiple ascending dose","score":0.996999979019165},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.6850000023841858},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.6449999809265137},{"id":"https://openalex.org/keywords/psoriatic-arthritis","display_name":"psoriatic arthritis","score":0.9919999837875366}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8445000052452087},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7494999766349792},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6899999976158142},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5209000110626221},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.4991999864578247},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4729999899864197},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.41609999537467957},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.40230000019073486},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35670000314712524},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.35120001435279846},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34299999475479126},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.34209999442100525},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3330000042915344},{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.3190000057220459},{"id":"https://openalex.org/C130523297","wikidata":"https://www.wikidata.org/wiki/Q14914487","display_name":"Tyrosine kinase 2","level":5,"score":0.30079999566078186},{"id":"https://openalex.org/C3020225094","wikidata":"https://www.wikidata.org/wiki/Q80091","display_name":"Area under curve","level":3,"score":0.2994000017642975},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2955000102519989},{"id":"https://openalex.org/C79410662","wikidata":"https://www.wikidata.org/wiki/Q1251001","display_name":"Dose\u2013response relationship","level":2,"score":0.2939000129699707},{"id":"https://openalex.org/C3019361228","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral dose","level":3,"score":0.27570000290870667},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.2556999921798706},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.2524999976158142},{"id":"https://openalex.org/C2777572184","wikidata":"https://www.wikidata.org/wiki/Q15749161","display_name":"Inflammatory Bowel Diseases","level":4,"score":0.25220000743865967},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.25060001015663147}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2026.1942461","doi":"https://doi.org/10.3389/fphar.2026.1942461","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1942461","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1942461/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13711260","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13711260/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13711260/pdf/fphar-17-1942461.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:42948471","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42948471","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Clinical Trial"},{"id":"pmh:oai:doaj.org/article:8717aa785acd4b6a85c6e4465482933e","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/8717aa785acd4b6a85c6e4465482933e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1942461","doi":"https://doi.org/10.3389/fphar.2026.1942461","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1942461","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1942461/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G1722223614","display_name":null,"funder_award_id":"2020ZX09201-025","funder_id":"https://openalex.org/F4320329860","funder_display_name":"National Science and Technology Major Project"}],"funders":[{"id":"https://openalex.org/F4320329860","display_name":"National Science and Technology Major Project","ror":null},{"id":"https://openalex.org/F4320330403","display_name":"Medical and Health Science and Technology Development Project of Shandong Province","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220830574.pdf","grobid_xml":"https://content.openalex.org/works/W7220830574.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W2892136519","https://openalex.org/W2903302497","https://openalex.org/W2939532730","https://openalex.org/W2973019461","https://openalex.org/W2979696485","https://openalex.org/W2986720246","https://openalex.org/W2999917455","https://openalex.org/W3005096969","https://openalex.org/W3017270234","https://openalex.org/W3129694639","https://openalex.org/W3174212996","https://openalex.org/W4214874713","https://openalex.org/W4220662174","https://openalex.org/W4223647933","https://openalex.org/W4310019147","https://openalex.org/W4313392224","https://openalex.org/W4386609479","https://openalex.org/W4387009793","https://openalex.org/W4391275328","https://openalex.org/W4392602545","https://openalex.org/W4392657203","https://openalex.org/W4396745638","https://openalex.org/W4401610730","https://openalex.org/W4402951012","https://openalex.org/W4403609797","https://openalex.org/W4404834062","https://openalex.org/W7124191926","https://openalex.org/W7133210149","https://openalex.org/W7138922692","https://openalex.org/W7148632384"],"related_works":["https://openalex.org/W3110971242","https://openalex.org/W7165544368","https://openalex.org/W7124140288","https://openalex.org/W4404832637","https://openalex.org/W4410769137","https://openalex.org/W4280581928","https://openalex.org/W7131277081","https://openalex.org/W3119900756","https://openalex.org/W2049344805","https://openalex.org/W3129694639"],"abstract_inverted_index":{"Objective":[0],"ICP-332":[1,119,131,164,239,306,349],"is":[2],"a":[3,53,64,80,259,351],"novel,":[4],"orally":[5],"administered":[6,92],"TYK2":[7,247],"inhibitor":[8],"with":[9,68,84,150,168,284,320],"high":[10],"selectivity,":[11],"intended":[12],"for":[13,95,354],"the":[14,103,141,155,198,209,223,236,295,302,315],"treatment":[15,353],"of":[16,63,178,189,246,272,348],"immune":[17],"inflammatory":[18,26],"diseases":[19],"such":[20],"as":[21,52,249,350],"atopic":[22],"dermatitis,":[23],"psoriatic":[24],"arthritis,":[25],"bowel":[27],"disease":[28],"and":[29,40,76,79,89,133,138,152,157,181,202,226,243,258,298,311,325],"lupus.":[30],"This":[31,48,144],"Phase":[32],"I":[33],"study":[34,49,145],"assessed":[35,139],"its":[36,337],"safety,":[37,273,309],"pharmacokinetics,":[38,338],"pharmacodynamics,":[39],"food":[41],"effect":[42],"in":[43,58,196,222,235,254,282,294,301],"Chinese":[44],"healthy":[45,59,148],"participants.":[46,60],"Methods":[47],"was":[50,100,136,194,290],"designed":[51],"randomized,":[54],"double-blind,":[55],"placebo-controlled":[56],"trial":[57],"It":[61],"consisted":[62],"single-ascending-dose":[65],"(SAD)":[66],"part":[67,83],"six":[69],"cohorts":[70,86],"(5,":[71],"15,":[72],"40,":[73],"80,":[74,88],"160,":[75],"320":[77],"mg)":[78,201,205],"multiple-ascending-dose":[81],"(MAD)":[82],"three":[85],"(40,":[87],"160":[90],"mg":[91,105,317],"once":[93],"daily":[94],"14":[96],"days).":[97],"Food-effect":[98],"evaluation":[99],"included":[101],"at":[102,232],"80":[104],"SAD":[106,156,199,224,296],"level.":[107],"In":[108,270],"each":[109],"cohort,":[110],"eight":[111],"participants":[112],"were":[113,127,277],"randomized":[114],"(6:2)":[115],"to":[116,129,171,219,229,280,292],"receive":[117],"either":[118],"or":[120,340],"placebo.":[121,269],"Following":[122],"oral":[123,162],"administration,":[124,163],"plasma":[125],"samples":[126],"collected":[128],"determine":[130],"concentrations,":[132],"safety":[134],"tolerance":[135],"monitored":[137],"throughout":[140],"study.":[142],"Results":[143],"enrolled":[146],"72":[147],"participants,":[149],"48":[151],"24":[153],"completing":[154],"MAD":[158,203,237,303],"phases,":[159],"respectively.":[160],"After":[161],"showed":[165],"rapid":[166,242,321],"absorption,":[167,322],"median":[169],"time":[170],"peak":[172],"concentration":[173],"(":[174,185,212],"T":[175],"max":[176],")":[177,188,215],"0.5\u20132.0":[179],"h":[180],"mean":[182],"elimination":[183],"half-life":[184],"t":[186],"\u00bd":[187],"2.692\u20137.275":[190],"h.":[191],"Dose-proportional":[192],"exposure":[193],"confirmed":[195],"both":[197],"(5\u2013320":[200],"(40\u2013160":[204],"phases;":[206],"area":[207],"under":[208],"concentration\u2013time":[210],"curve":[211],"AUC":[213],"last":[214],"ranged":[216],"from":[217,227],"146.3":[218],"11,667.5":[220],"h\u00b7ng/mL":[221,231],"phase":[225,297],"1386.0":[228],"6513.5":[230],"steady":[233],"state":[234],"phase.":[238,304],"also":[240],"induced":[241],"dose-dependent":[244],"suppression":[245],"activity,":[248],"evidenced":[250],"by":[251],"dose-related":[252],"reductions":[253],"high-sensitivity":[255],"C-reactive":[256],"protein":[257,265],"trend":[260],"toward":[261],"decreased":[262],"interferon":[263],"gamma-induced":[264],"10":[266],"levels":[267],"versus":[268],"terms":[271],"treatment-emergent":[274],"adverse":[275,328],"events":[276],"all":[278],"mild":[279],"moderate":[281],"severity,":[283],"no":[285],"participant":[286],"withdrawals.":[287],"TEAE":[288],"incidence":[289],"comparable":[291],"placebo":[293],"slightly":[299],"higher":[300],"Conclusion":[305],"exhibited":[307],"favorable":[308],"pharmacokinetics":[310],"pharmacodynamics":[312,339],"profiles":[313],"across":[314],"5\u2013320":[316],"dose":[318],"range,":[319],"dose-proportional":[323],"exposure,":[324],"mild,":[326],"reversible":[327],"events.":[329],"A":[330],"high-fat":[331],"meal":[332],"did":[333],"not":[334],"significantly":[335],"affect":[336],"safety.":[341],"These":[342],"results":[343],"support":[344],"continued":[345],"clinical":[346],"development":[347],"promising":[352],"autoimmune":[355],"diseases.":[356],"Clinical":[357],"Trial":[358],"Registration":[359],"http://www.chinadrugtrials.org.cn/index.html":[360],"CTR20211781.":[361]},"counts_by_year":[],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2026-10-08T00:00:00"}